Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Open-Angle Glaucoma (OAG) Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, there has been considerable expansion in the open-angle glaucoma (OAG) market. We anticipate growth from $6.13 billion in 2024 to $6.55 billion in 2025, marking a compound annual growth rate (CAGR) of 6.8%. This upswing during the historical period can be traced back to factors such as an upsurge in glaucoma cases in elderly populations, heightened consciousness about the early diagnosis of ocular diseases, escalated spending on healthcare, implementation of vision care schemes by governments, and augmented global ophthalmology operations.

The market size for open-angle glaucoma (OAG) is projected to experience a significant rise in the coming years, soaring to a value of $8.42 billion in 2029, with a compound annual growth rate (CAGR) of 6.5%. The augmentation observed in the forecast period is due to a surge in demand for combination therapies, an increased emphasis on personalized medicine, better reimbursement policies for glaucoma treatments, an escalating frequency of lifestyle-induced ocular conditions, and a rising preference for non-invasive diagnostic techniques. Over that forecast period, major movements are expected to be seen, such as the increased utilization of AI in glaucoma diagnostics, a switch towards outpatient glaucoma surgical procedures, higher usage of sustained-release glaucoma implants, greater integration of wearable technology for monitoring intraocular pressure, and an enhanced focus on sustainability within medical device production.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Open-Angle Glaucoma (OAG) Market?

The escalating cognizance of eye maladies is anticipated to stimulate the advancement of the open-angle glaucoma (OAG) market in the future. Eye maladies involve health issues affecting the anatomy, functionality, or sight of the eyes, varying from minor troubles like dry eye to severe ailments like glaucoma and macular degeneration. They are becoming more prevalent due to the aging population, extended screen usage, growing incidences of diabetes, environmental contamination, and lifestyle choices that put eye health at risk. Open-angle glaucoma (OAG), a main cause of vision loss, particularly in older individuals, highlights the important need for regular eye check-ups, prompt identification, and proactive management to prevent permanent loss of vision. For instance, the Royal National Institute of Blind People (RNIB), a sight loss charity based in the UK, reported in October 2023 that eye care outpatient appointments in the UK topped eight million in 2021/22, positioning it as the most sought-after specialty. In addition, the count of individuals experiencing sight loss, which currently exceeds two million, is expected to surge to over four million by 2050. Thus, the escalating cognizance of eye maladies is fuelling growth in the open-angle glaucoma (OAG) market.

Which Key Market Segments Comprise the Open-Angle Glaucoma (OAG) Market and Drive Its Revenue Growth?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Which Areas Are Leading Regions in the Open-Angle Glaucoma (OAG) Market Expansion Across the Globe?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Open-Angle Glaucoma (OAG) Industry?

Leading firms in the open-angle glaucoma (OAG) marketplace are placing high importance on forging new, cutting-edge solutions such as minimally invasive glaucoma devices (MIGDs). The aim is to present improved and less intrusive alternatives for handling primary open-angle glaucoma, minimizing the dependence on typical treatments. MIGDs are a variety of surgical implants and methodologies conceived to decrease intraocular pressure in glaucoma sufferers through minor incisions and minor ocular tissue disturbance. For instance, iSTAR Medical, a medtech entity from Belgium, introduced MINIject in the Netherlands in December 2023. This treatment for primary open-angle glaucoma, integrated with a unique porous STAR material, enhances liquid outflow and reduces IOP. MINIject therefore marks an important advancement in glaucoma treatment, offering a safer and more efficient solution for managing this prominent cause of irreversible blindness, thereby reducing reliance on traditional treatments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

How Is the Open-Angle Glaucoma (OAG) Market Conceptually Defined?

Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model